Cardiomyopathy in Coronavirus Disease Survivors: Mechanism, Management and Prevention

Cardiomyopathy in Coronavirus Disease Survivors: Mechanism, Management and Prevention

Coronavirus disease (COVID-19) caused by infection of SARS-CoV-2 as of April 2020 has been confirmed in more than 2.3 million people, with more than 150 thousands deaths across the globe. It has been known that COVID-19 patients with underlying cardiovascular diseases and its risks including: hyper...

Full description

Bibliographic Details
Main Author:	Renan Sukmawan
Format:	Article
Language:	English
Published:	Indonesian Heart Association 2020-05-01
Series:	Majalah Kardiologi Indonesia
Subjects:	COVID-19, cardiomyopathy, myocarditis
Online Access:	http://www.ijconline.id/index.php/ijc/article/view/1012

Similar Items

The mRNA-Based coronavirus disease-2019 vaccine-induced severe cardiomyopathy: A rare incident
by: Afshan Jamil, et al.
Published: (2022-01-01)

Editorial: Paediatric Cardiomyopathies
by: Emanuele Monda, et al.
Published: (2021-05-01)

Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease
by: Riccardo Bariani, et al.
Published: (2022-09-01)

Acute heart failure due to COVID-19 related myocardial injury and de novo hypertensive cardiomyopathy: a challenging diagnosis
by: Matteo Pernigo, et al.
Published: (2021-09-01)

Expert Consensus for Management of Myocardial Injury, Myocarditis, and Post-infection Condition with Coronavirus Disease 2019 (Second Edition)
by: National Center of Gerontology, Electrocardiology and Cardiac Function Branch of Chinese Geriatric Society, Imaging Group of Cardiovascular Department, Beijing Medical Association, Chinese Medical and Health Culture Association Cardiovascular Health and Science Sports Branch of China Health Culture Association
Published: (2023-05-01)

Pemphigus‐associated cardiomyopathy: report of autoimmune myocarditis and review of literature
by: Andrea Frustaci, et al.
Published: (2021-10-01)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
by: Andrea Frustaci, et al.
Published: (2018-09-01)

Inflammatory cardiomyopathy: state-of-the-art
by: E A Belyavsky, et al.
Published: (2010-08-01)

DIAGNOSTIC SIGNIFICANCE OF IMMUNITY MARKERS IN INFLAMMATORY CARDIOMYOPATHY PATIENTS
by: S. N. Tereschenko, et al.
Published: (2017-02-01)

Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies
by: Nicolas Piriou, et al.
Published: (2020-08-01)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
by: Inês Teixeira Farinha, et al.
Published: (2016-11-01)

Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment
by: Felicitas Escher, et al.
Published: (2015-12-01)

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
by: Edgardo Alania-Torres, et al.
Published: (2021-10-01)

A case report of myocarditis masquerading as hypertrophic cardiomyopathy
by: Jaclyn R Giafaglione, et al.
Published: (2020-01-01)

The inflammatory spectrum of cardiomyopathies
by: Nicolas Musigk, et al.
Published: (2024-02-01)

Cardiomyopathy and Death Following Chikungunya Infection: An Increasingly Common Outcome
by: Elizabeth M. Traverse, et al.
Published: (2021-06-01)

A case of severe cardiomyopathy due to COVID-induced myocarditis, completely resolved after colchicine and immunoglobulin therapy
by: Su Khine, et al.
Published: (2023-08-01)

Endomyocardial Biopsy in Pediatric Myocarditis and Dilated Cardiomyopathy: A Tool in Search for a Role
by: Mara Pilati, et al.
Published: (2022-01-01)

Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy
by: Ayman K.M. Hassan, et al.
Published: (2017-03-01)

Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
by: Maurits A. Sikking, et al.
Published: (2023-06-01)

Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children
by: Surabhi Reddy, et al.
Published: (2017-01-01)

Role of Endomyocardial Biopsy in Diagnostics of Myocarditis
by: Liga Vidusa, et al.
Published: (2022-08-01)

Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis
by: Saikrishna Reddy, et al.
Published: (2020-01-01)

Editorial: Acquired Heart Disease in Children: Pathogenesis, Diagnosis and Management
by: Ying Liao, et al.
Published: (2021-07-01)

Acute myocarditis morphologically mimicking reverse takotsubo cardiomyopathy
by: Sherief Sulaiman, et al.
Published: (2017-01-01)

DSP c.6310delA p.(Thr2104Glnfs*12) associates with arrhythmogenic cardiomyopathy, increased trabeculation, curly hair, and palmoplantar keratoderma
by: Krista Heliö, et al.
Published: (2023-03-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

Inflammation—A Possible Link between Myocarditis and Arrhythmogenic Cardiomyopathy
by: Ioan Radu Lala, et al.
Published: (2024-01-01)

Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
by: Haijiang Dai, et al.
Published: (2021-02-01)

Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease With Viral Infection: Have We Found the Holy Grail?
by: Jun-Jun Yeh, et al.
Published: (2022-06-01)

Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy
by: Angelos G. Rigopoulos, et al.
Published: (2019-06-01)

Viral genome changes and the impact of viral genome persistence in myocardium of patients with inflammatory cardiomyopathy
by: Dalibor Mlejnek, et al.
Published: (2018-10-01)

Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni
by: Nobuko Kojima, et al.
Published: (2022-03-01)

Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop
by: Daniela Čiháková, et al.
Published: (2022-09-01)

Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy
by: Zhe Lei, et al.
Published: (2024-02-01)

SUBACUTE MYOCARDITIS: MYTHS AND REALITY
by: P. A. Shesternya, et al.
Published: (2014-07-01)

SUBACUTE MYOCARDITIS: MYTHS AND REALITY
by: P. A. Shesternya, et al.
Published: (2014-07-01)

Treatment efficacy of arrhythmias and dilated cardiomyopathy syndrome of immune-inflammatory nature using plasmapheresis
by: V. A. Kulikova, et al.
Published: (2018-12-01)

NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
by: Qing Kong, et al.
Published: (2022-09-01)

Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report
by: Rahim Nejadrahim, et al.
Published: (2021-03-01)